Published in Contraception
To explore abortion method preference, interpersonal and cultural factors associated with preference, and whether, among people with a preference for medication abortion, those presenting past 10 weeks gestation had experienced more obstacles to care. In 2019, we invited people aged 15 to 45 years presenting to 4 U.S. abortion clinics to complete a...
Published in Contraception
To summarize the effects of routine, opt-out abortion and family planning residency training on obstetrics and gynecology (ob-gyn) residents' clinical skills in uterine evacuation and intentions to provide abortion care after residency. Data from ob-gyn residency programs supported during the first 20 years of the Kenneth J. Ryan Residency Training...
Published in Contraception
To evaluate levonorgestrel 52 mg intrauterine system (IUS) expulsion risk by menstrual cycle day of insertion (days 1-8 vs. days 9 and beyond) in women using the IUS for non-contraceptive indications. We performed a retrospective cohort study of patients with a levonorgestrel IUS inserted for the management of non-contraceptive, gynecologic conditi...
Published in Contraception
To assess the effect on hemostasis parameters of a new combined oral contraceptive (COC). In this randomized, single centre, open-label, exploratory study, healthy women received either 15 mg estetrol/3 mg drospirenone (E4/DRSP) (n = 39), 30 mcg ethinylestradiol/150 mcg levonorgestrel (EE/LNG) (n = 30), or 20 mcg ethinylestradiol/3 mg drospirenone ...
Published in Contraception
We report a case of severe systemic delayed dermatitis in a patient with nickel-titanium sterilization microinserts placement complicated by uterine perforation and polyethylene terephthalate (PET) exposure. We hypothesize that delayed dermatitis may be caused by the exposure of PET fibers in this patient with underlying autoimmune disorder. Furthe...
Published in Contraception
To assess the contraceptive efficacy, safety, and tolerability of a contraceptive transdermal delivery system, (TDS; TWIRLAⓇ) containing levonorgestrel (LNG) and ethinyl estradiol (EE). This single-arm, open-label, multicenter, 1-year (13 cycle), phase 3 study enrolled sexually active women ≥18 years old at risk for pregnancy irrespective of body m...
Published in Contraception
To evaluate the cost-effectiveness of providing contraceptive implants in school-based health centers (SBHCs) compared to the practice of referring adolescents to non-SBHCs in New York City. We developed a microsimulation model of teen pregnancy to estimate the cost-effectiveness of immediate provision of contraceptive implants at SBHCs over a 3-ye...
Published in Contraception
To define serum human chorionic gonadotropin (hCG) decline following complete aspiration abortion. We performed a secondary analysis of 86 patients who underwent uncomplicated aspiration abortion for ultrasound-confirmed pregnancy ≤42 days gestation and had serum hCG at the time of aspiration and within 3 days postprocedure. Median hCG declines wer...
Published in Contraception
To evaluate the effectiveness of a contraceptive decision aid in reducing decisional conflict among women seeking reversible contraception. We conducted a randomized trial of a computer-based decision aid compared to a control group for women presenting for reversible contraception at two clinics affiliated with an academic medical center. The prim...
Published in Contraception
